Omnicell (OMCL) Cost of Revenue (2010 - 2026)
Omnicell's (OMCL) quarterly Cost of Revenue came in at $159.3 million in Q2 2026, down 2.22% year-over-year from $162.9 million in Q2 2025, and down 6.04% quarter-over-quarter from $169.5 million in Q1 2026.
Analysis
Omnicell (OMCL) Cost of Revenue (2010 - 2026) Analysis & Trends
Omnicell (OMCL) has reported Cost of Revenue for 17 consecutive years, with $159.3 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Cost of Revenue fell 2.22% year-over-year to $159.3 million in Q2 2026; TTM through Jun 2026 was $688.6 million, a 6.44% increase from a year earlier, with the FY2025 full-year figure at $681.4 million, up 6.26% from the prior year.
- Cost of Revenue was $159.3 million for Q2 2026 at Omnicell, down from $169.5 million in the prior quarter.
- Over five years, Cost of Revenue peaked at $189.0 million in Q3 2022 and troughed at $153.4 million in Q4 2023.
- A 5-year average of $167.1 million and a median of $165.4 million in 2023 frame the typical range for Cost of Revenue.
- Across the five-year window, Cost of Revenue jumped 30.27% in 2022 and fell 12.78% in 2023, its largest moves.
- Over 5 years, Cost of Revenue stood at $175.9 million in 2022, then slipped by 12.78% to $153.4 million in 2023, then rose by 7.61% to $165.1 million in 2024, then rose by 11.23% to $183.7 million in 2025, then retreated by 13.28% to $159.3 million in 2026.
- The last three Cost of Revenue figures came in at $159.3 million (Q2 2026), $169.5 million (Q1 2026), and $183.7 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 187.42 Bn | 182.47 Bn | 7.27 Bn | 5.33 Bn |
| 2 | Intuitive Surgical | 129.78 Bn | 124.69 Bn | 1.96 Bn | 931.90 Mn |
| 3 | Medtronic | 120.53 Bn | 112.33 Bn | 6.34 Bn | 3.42 Bn |
| 4 | Stryker | 116.28 Bn | 112.80 Bn | 4.50 Bn | 2.09 Bn |
| 5 | Boston Scientific | 69.29 Bn | 68.99 Bn | 3.85 Bn | 1.59 Bn |
| 6 | Edwards Lifesciences | 51.83 Bn | 47.68 Bn | 1.35 Bn | 392.40 Mn |
| 7 | Alcon | 34.36 Bn | 32.91 Bn | 1.68 Bn | 18.00 Mn |
| 8 | Dexcom | 33.17 Bn | 31.23 Bn | 830.00 Mn | 478.40 Mn |
| 9 | Resmed | 32.94 Bn | 31.47 Bn | 861.22 Mn | 602.43 Mn |
| 10 | Omnicell | 1.57 Bn | 1.28 Bn | 152.94 Mn | 159.27 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 159.27 Mn |
| Mar 31, 2026 | 169.52 Mn |
| Dec 31, 2025 | 183.66 Mn |
| Sep 30, 2025 | 176.13 Mn |
| Jun 30, 2025 | 162.88 Mn |
| Mar 31, 2025 | 158.73 Mn |
| Dec 31, 2024 | 165.12 Mn |
| Sep 30, 2024 | 160.15 Mn |
| Jun 30, 2024 | 162.44 Mn |
| Mar 31, 2024 | 153.53 Mn |
| Dec 31, 2023 | 153.44 Mn |
| Sep 30, 2023 | 166.70 Mn |
| Jun 30, 2023 | 164.53 Mn |
| Mar 31, 2023 | 165.60 Mn |
| Dec 31, 2022 | 175.92 Mn |
| Sep 30, 2022 | 188.96 Mn |
| Jun 30, 2022 | 173.29 Mn |
| Mar 31, 2022 | 168.78 Mn |
| Dec 31, 2021 | 161.74 Mn |
| Sep 30, 2021 | 149.62 Mn |